TIPS for treatment of refractory ascites in cirrhosis
10.3969/j.issn.1001-5256.2022.11.034
- VernacularTitle:经颈静脉肝内门体分流术治疗肝硬化顽固性腹水的现状
- Author:
Lanjing WANG
1
,
2
;
Xin YAO
1
;
Jianping QIN
1
;
Shanhong TANG
1
,
2
Author Information
1. Department of Gastroenterology, The General Hospital of Western Theater Command, Chengdu 610083, China
2. Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646099, China
- Publication Type:Reviews
- Keywords:
Liver Cirrhosis;
Ascites;
Portasystemic Shunt, Transjugular Intrahepatic;
Hypertension, Portal
- From:
Journal of Clinical Hepatology
2022;38(11):2606-2610
- CountryChina
- Language:Chinese
-
Abstract:
Refractory ascites (RA) is one of the complications of portal hypertension in decompensated cirrhosis. It is hard to treat RA and there is high mortality in patients with RA. Nowadays, Transjugular Intrahepatic Portosystemic Shunt (TIPS) is used as a second-line treatment for RA. TIPS can improve the clinical symptoms of ascites by reducing the pressure of portal vein. Accumulated studies have proposed that applications of polytetrafluoroethylene covered stents and careful selection of applied patients can improve the prognosis of RA patients. Therefore, some scholars propose that TIPS can be used as one of the first-line treatments for RA. This review will comprehensively summarize current understanding of TIPS in treating RA patients and elaborate the most recently updated progress of the relevant researches, aiming to promote the development of studies on using TIPS as a treatment for RA patients in China.
